Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
tamoxifen, letrozole, anastrozole, or exemestane
DRUG
2 trials
Sponsors
Shayna Showalter, MD
, University of Virginia
Conditions
Breast Cancer Female
Phase 2
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
Active, not recruiting
NCT04272801
Shayna Showalter, MD
Breast Cancer Female
Start: 2020-04-07
End: 2026-06-01
Updated: 2025-10-22
Phase 3
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Recruiting
NCT06507618
University of Virginia
Breast Cancer Female
Start: 2024-07-19
End: 2034-03-01
Target: 354
Updated: 2026-06-30
Related Papers
The pre-operative window of endocrine therapy to inform radiation therapy decisions (POWER) trial: Baseline patient beliefs about breast cancer and endocrine therapy.
Journal of Clinical Oncology
2024-06-01
Abstract PO3-01-10: Changes in Patient-Reported Outcomes with 3 Months of Pre-operative Endocrine Therapy in the POWER Trial
Cancer Research
2024-05-02
The POWER-PAK Score Characterizes Tumor Response to 3 Months of Preoperative Endocrine Therapy.
2023-07-15